vs
Side-by-side financial comparison of ALBANY INTERNATIONAL CORP (AIN) and Hims & Hers Health, Inc. (HIMS). Click either name above to swap in a different company.
Hims & Hers Health, Inc. is the larger business by last-quarter revenue ($617.8M vs $321.2M, roughly 1.9× ALBANY INTERNATIONAL CORP). ALBANY INTERNATIONAL CORP runs the higher net margin — 4.3% vs 3.3%, a 1.0% gap on every dollar of revenue. On growth, Hims & Hers Health, Inc. posted the faster year-over-year revenue change (28.4% vs 12.0%). ALBANY INTERNATIONAL CORP produced more free cash flow last quarter ($51.4M vs $-2.5M). Over the past eight quarters, Hims & Hers Health, Inc.'s revenue compounded faster (49.0% CAGR vs 1.2%).
Albany International Corp is a global advanced materials and industrial technology company. It operates two core segments: Machine Clothing producing custom engineered fabrics for paper and other industrial manufacturing processes, and Engineered Composites developing high-performance composite components primarily for the aerospace and defense sectors, serving customers across North America, Europe, Asia and other global regions.
Hims & Hers Health, Inc. is an American telehealth company established in 2017. The company provides prescription medications, over-the-counter medications, and personal care products.
AIN vs HIMS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $321.2M | $617.8M |
| Net Profit | $13.9M | $20.6M |
| Gross Margin | 31.1% | 71.9% |
| Operating Margin | 9.3% | 1.5% |
| Net Margin | 4.3% | 3.3% |
| Revenue YoY | 12.0% | 28.4% |
| Net Profit YoY | -21.5% | -20.8% |
| EPS (diluted) | $0.56 | $0.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $321.2M | $617.8M | ||
| Q3 25 | $261.4M | $599.0M | ||
| Q2 25 | $311.4M | $544.8M | ||
| Q1 25 | $288.8M | $586.0M | ||
| Q4 24 | $286.9M | $481.1M | ||
| Q3 24 | $298.4M | $401.6M | ||
| Q2 24 | $332.0M | $315.6M | ||
| Q1 24 | $313.3M | $278.2M |
| Q4 25 | $13.9M | $20.6M | ||
| Q3 25 | $-97.8M | $15.8M | ||
| Q2 25 | $9.2M | $42.5M | ||
| Q1 25 | $17.4M | $49.5M | ||
| Q4 24 | $17.7M | $26.0M | ||
| Q3 24 | $18.0M | $75.6M | ||
| Q2 24 | $24.6M | $13.3M | ||
| Q1 24 | $27.3M | $11.1M |
| Q4 25 | 31.1% | 71.9% | ||
| Q3 25 | -19.1% | 73.8% | ||
| Q2 25 | 31.3% | 76.4% | ||
| Q1 25 | 33.4% | 73.5% | ||
| Q4 24 | 31.5% | 76.8% | ||
| Q3 24 | 30.3% | 79.2% | ||
| Q2 24 | 33.9% | 81.3% | ||
| Q1 24 | 34.7% | 82.4% |
| Q4 25 | 9.3% | 1.5% | ||
| Q3 25 | -44.6% | 2.0% | ||
| Q2 25 | 7.2% | 4.9% | ||
| Q1 25 | 9.8% | 9.9% | ||
| Q4 24 | 8.5% | 3.9% | ||
| Q3 24 | 8.4% | 5.6% | ||
| Q2 24 | 12.9% | 3.5% | ||
| Q1 24 | 12.4% | 3.6% |
| Q4 25 | 4.3% | 3.3% | ||
| Q3 25 | -37.4% | 2.6% | ||
| Q2 25 | 2.9% | 7.8% | ||
| Q1 25 | 6.0% | 8.4% | ||
| Q4 24 | 6.2% | 5.4% | ||
| Q3 24 | 6.0% | 18.8% | ||
| Q2 24 | 7.4% | 4.2% | ||
| Q1 24 | 8.7% | 4.0% |
| Q4 25 | $0.56 | $0.08 | ||
| Q3 25 | $-3.37 | $0.06 | ||
| Q2 25 | $0.31 | $0.17 | ||
| Q1 25 | $0.56 | $0.20 | ||
| Q4 24 | $0.57 | $0.10 | ||
| Q3 24 | $0.57 | $0.32 | ||
| Q2 24 | $0.79 | $0.06 | ||
| Q1 24 | $0.87 | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $112.3M | $228.6M |
| Total DebtLower is stronger | $455.7M | — |
| Stockholders' EquityBook value | $726.2M | $540.9M |
| Total Assets | $1.7B | $2.2B |
| Debt / EquityLower = less leverage | 0.63× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $112.3M | $228.6M | ||
| Q3 25 | $108.3M | $345.8M | ||
| Q2 25 | $106.7M | $1.1B | ||
| Q1 25 | $119.4M | $273.7M | ||
| Q4 24 | $115.3M | $220.6M | ||
| Q3 24 | $127.2M | $165.5M | ||
| Q2 24 | $116.4M | $129.3M | ||
| Q1 24 | $125.4M | $105.2M |
| Q4 25 | $455.7M | — | ||
| Q3 25 | $480.6M | — | ||
| Q2 25 | $444.7M | — | ||
| Q1 25 | $416.4M | — | ||
| Q4 24 | $318.5M | — | ||
| Q3 24 | $362.2M | — | ||
| Q2 24 | $377.1M | — | ||
| Q1 24 | $439.1M | — |
| Q4 25 | $726.2M | $540.9M | ||
| Q3 25 | $739.3M | $581.0M | ||
| Q2 25 | $888.6M | $562.7M | ||
| Q1 25 | $900.0M | $549.3M | ||
| Q4 24 | $943.5M | $476.7M | ||
| Q3 24 | $991.0M | $440.1M | ||
| Q2 24 | $967.5M | $362.0M | ||
| Q1 24 | $967.5M | $344.5M |
| Q4 25 | $1.7B | $2.2B | ||
| Q3 25 | $1.7B | $2.2B | ||
| Q2 25 | $1.7B | $1.9B | ||
| Q1 25 | $1.7B | $891.7M | ||
| Q4 24 | $1.6B | $707.5M | ||
| Q3 24 | $1.8B | $602.3M | ||
| Q2 24 | $1.8B | $480.5M | ||
| Q1 24 | $1.8B | $448.1M |
| Q4 25 | 0.63× | — | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | 0.50× | — | ||
| Q1 25 | 0.46× | — | ||
| Q4 24 | 0.34× | — | ||
| Q3 24 | 0.37× | — | ||
| Q2 24 | 0.39× | — | ||
| Q1 24 | 0.45× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $73.7M | $61.3M |
| Free Cash FlowOCF − Capex | $51.4M | $-2.5M |
| FCF MarginFCF / Revenue | 16.0% | -0.4% |
| Capex IntensityCapex / Revenue | 6.9% | 10.3% |
| Cash ConversionOCF / Net Profit | 5.31× | 2.98× |
| TTM Free Cash FlowTrailing 4 quarters | $82.6M | $57.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $73.7M | $61.3M | ||
| Q3 25 | $43.9M | $148.7M | ||
| Q2 25 | $32.7M | $-19.1M | ||
| Q1 25 | $2.1M | $109.1M | ||
| Q4 24 | $78.5M | $86.4M | ||
| Q3 24 | $47.0M | $85.3M | ||
| Q2 24 | $83.4M | $53.6M | ||
| Q1 24 | $9.6M | $25.8M |
| Q4 25 | $51.4M | $-2.5M | ||
| Q3 25 | $25.9M | $79.3M | ||
| Q2 25 | $18.8M | $-69.5M | ||
| Q1 25 | $-13.5M | $50.1M | ||
| Q4 24 | $60.2M | $59.5M | ||
| Q3 24 | $31.6M | $79.4M | ||
| Q2 24 | $63.6M | $47.6M | ||
| Q1 24 | $-17.3M | $11.8M |
| Q4 25 | 16.0% | -0.4% | ||
| Q3 25 | 9.9% | 13.2% | ||
| Q2 25 | 6.0% | -12.8% | ||
| Q1 25 | -4.7% | 8.5% | ||
| Q4 24 | 21.0% | 12.4% | ||
| Q3 24 | 10.6% | 19.8% | ||
| Q2 24 | 19.2% | 15.1% | ||
| Q1 24 | -5.5% | 4.3% |
| Q4 25 | 6.9% | 10.3% | ||
| Q3 25 | 6.9% | 11.6% | ||
| Q2 25 | 4.5% | 9.3% | ||
| Q1 25 | 5.4% | 10.1% | ||
| Q4 24 | 6.4% | 5.6% | ||
| Q3 24 | 5.2% | 1.5% | ||
| Q2 24 | 6.0% | 1.9% | ||
| Q1 24 | 8.6% | 5.0% |
| Q4 25 | 5.31× | 2.98× | ||
| Q3 25 | — | 9.43× | ||
| Q2 25 | 3.56× | -0.45× | ||
| Q1 25 | 0.12× | 2.20× | ||
| Q4 24 | 4.44× | 3.32× | ||
| Q3 24 | 2.61× | 1.13× | ||
| Q2 24 | 3.39× | 4.03× | ||
| Q1 24 | 0.35× | 2.32× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AIN
| Transferred At Point In Time | $176.5M | 55% |
| Engineered Composites Other | $99.3M | 31% |
| Engineered Composites ASC | $44.5M | 14% |
| Transferred Over Time | $1.0M | 0% |
HIMS
Segment breakdown not available.
